Pharmaceutical companies have these market demands, among others, when it comes to developing and selling new products:
Biocatalysts Ltd has been reacting to these requirements and started together with BRAIN Biotech Zwingenberg the initiative "BRAIN-Biocatalysts Life Science Solutions".
Combined expertise: The BRAIN-Biocatalysts Life Science Solutions is the result of a powerful combination of BRAIN Biotech’s expertise in enzyme discovery (MetXtraTM) and enzyme engineering with Biocatalysts Ltd’s commercial-scale manufacturing capabilities.
End-to-end services: Through this integration, the initiative offers end-to-end services, from enzyme discovery and industrial production strains to fermentation and production, while ensuring that customers retain full intellectual property rights.
The offer is designed to advance enzyme solutions in the life sciences, especially for
Transparent IP structure: BRAIN-Biocatalysts Life Science Solutions is particularly appealing for pharmaceutical companies looking to scale biocatalysis due to its ability to streamline the entire development pipeline under a transparent IP structure.
Rapid scaling: The “Plug & Produce” microbial fermentation platform and Cardiff-based production facilities also support rapid scaling, which helps reduce both time and costs involved in bringing new biocatalytic processes to market.
Overall, BRAIN-Biocatalysts Life Science Solutions´unique offering is ideal for companies aiming to scale biocatalysis processes, with a streamlined development pipeline. The solutions address key market needs, like scalability, IP security, and custom enzyme design, enabling life sciences companies to innovate without limitations.
If you want to learn more about BRAIN-Biocatalysts Lilfe Scienc Solutions, please contact our experts or our contact Biocatalysts Ltd.
